Americans flocking to India for stem cell therapyMay 28th, 2012 - 11:06 am ICT by IANS
Washington, May 28 (IANS) A growing number of Americans are travelling to India to seek treatment for rare diseases through India’s experimental embryonic stem cell therapy, according to an investigative report.
Among them Cash Burnaman, a 6-year-old South Carolina boy, who travelled with his parents to India seeking treatment for a rare genetic condition that has left him developmentally disabled, CNN reported.
“Cash is mute. He walks with the aid of braces. To battle his incurable condition, which is so rare it doesn’t have a name, Cash has had to take an artificial growth hormone for most of his life,” it said.
His divorced parents, Josh Burnaman and Stephanie Krolick, have paid tens of thousands of dollars to have Cash undergo experimental injections of human embryonic stem cells at New Delhi’s NuTech Mediworld run by Dr. Geeta Shroff, a retired obstetrician and self-taught embryonic stem cell practitioner.
Shroff first treated Cash — who presents symptoms similar to Down Syndrome — in 2010. “I am helping improve their quality of life,” she told CNN.
After five weeks of treatment, Cash and his parents returned home to the US. That’s when Cash began walking with the aid of braces for the first time.
For four or five weeks of treatment, Shroff says she has charged her 87 American patients an average of $25,000.
But doctors cited by CNN said all that work and hope and money Cash’s supporters have funnelled into his experimental therapy likely will have no medical benefits.
“There is zero evidence for what she (Shroff ) is doing being effective,” Rutgers University’s Dr. Wise Young, a leading US neuroscientist, was quoted as saying.
“It’s concerning no matter how you look at it,” said CNN chief medical correspondent Dr. Sanjay Gupta. “Frankly it’s the complete wrong way of going about this sort of science.”
A leading Indian neurosurgeon, Dr. P.N. Tandon, cited by CNN agreed there was zero medical evidence of the effectiveness of embryonic stem cell therapy like that provided at NuTech Mediworld
But inside her clinic, surrounded by patients, Shroff disagreed. “Success,” she told CNN, “is defined differently by various groups of people within that therapy mode. So as of right now, almost everyone — greater than 90 percent — have had success.”
- Embryo stem cell therapy brings hope to those with incurable diseases - Jun 10, 2012
- Stem cell regulations shouldn't stifle research: Indian experts - Apr 21, 2011
- Your child's milk tooth can save her life - Mar 30, 2012
- When a quadriplegic inspired Gilchrist to script cricket history - Apr 23, 2011
- New stem cell therapy may help heal acute lung injury - Feb 04, 2010
- London hospital to do Europe's first embryonic stem cell trial - Sep 24, 2011
- Research may pave way for new regenerative therapies - May 04, 2011
- New way to screen breast cancer cells' ability to metastasize - Jan 09, 2011
- Mandira Bedi to endorse stem cell bank - Jun 03, 2011
- Stem-cell treatment helps American see again, view Taj Mahal - Dec 06, 2011
- Boffins 'reprogram' adult mouse fat cells into stem cells - Jul 27, 2010
- Boffins identify key stem cells for eating, sex - Jul 22, 2010
- Menstrual blood stem cells can treat many ailments - May 04, 2011
- Indian doctor condemned over miracle cure claims - Nov 07, 2009
- New stem cells could help heal damaged hearts - Dec 23, 2011
Tags: chief medical correspondent, cnn, divorced parents, dr sanjay gupta, embryonic stem cell, embryonic stem cells, experimental therapy, human embryonic stem cells, incurable condition, investigative report, money cash, nutech, rare diseases, rare genetic condition, rutgers university, sanjay gupta, stem cell therapy, travelling to india, work and hope, zero evidence